| Name |
Klindamicin-MIP 150 mg/ml otopina za injekciju/infuziju |
| Former Name |
Clindamycin MIP 600 mg/4 ml otopina za injekcije; Clindamycin MIP 900 mg/6 ml otopina za injekcije |
| Marketing Authorisation Number |
HR-H-729920283 |
| Active Substance |
klindamicinfosfat |
| Composition |
1 ml otopine za injekciju sadrži 150 mg klindamicina u obliku klindamicinfosfata |
| Pharmaceutical Form |
Otopina za injekciju / infuziju |
| Manufacturer |
MIP Pharma GmbH, St. Ingbert, Njemačka |
| Marketing Authorisation Holder |
MIP Pharma Croatia d.o.o., Mihanovićeva 14, Zagreb, Hrvatska |
| Marketing Authorisation Date |
25.07.2016 |
| MA Period of Validity |
unlimited |
| Classification Number |
UP/I-530-09/14-02/274 |
| Registration Number |
381-12-01/70-16-07 |
| Prescription |
na recept |
| Type of prescription |
ograničeni recept
|
| Distribution |
u ljekarni |
| Advertising to general public |
zabranjeno |
| ATC Code |
J01FF01 |
| Medicinal product marketed in the Croatia |
Da |
| SmPC |
download |
| PL |
download |
